Strategies for optimizing targeting and delivery of mucosal HIV vaccines (Q37554135)

21 August 2017

1 reference

title

Strategies for optimizing targeting and delivery of mucosal HIV vaccines (English)

1 reference

21 August 2017

Jeffrey D Ahlers

1

1 reference

21 August 2017

Igor M Belyakov

series ordinal

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

European Journal of Immunology

21 August 2017

1 reference

21 August 2017

39

1 reference

21 August 2017

10

1 reference

21 August 2017

2657-2669

1 reference

A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/human immunodeficiency viral depletion of mucosal CD4+ T cells

21 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Progress on new vaccine strategies against chronic viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Cutting edge: gut microenvironment promotes differentiation of a unique memory CD8 T cell population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Cutting edge: migration to nonlymphoid tissues results in functional conversion of central to effector memory CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Rapid development of T cell memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Cutting edge: Peyer's patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFbeta, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph node

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Mucosal HIV-1 pox virus prime-boost immunization induces high-avidity CD8+ T cells with regime-dependent cytokine/granzyme B profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Mucosally delivered dendritic cells activate T cells independently of IL-12 and endogenous APCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Novel vaccination protocol with two live mucosal vectors elicits strong cell-mediated immunity in the vagina and protects against vaginal virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

IFN-gamma and R-848 dependent activation of human monocyte-derived dendritic cells by Neisseria meningitidis adhesin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

The context of epitope presentation can influence functional quality of recalled influenza A virus-specific memory CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

No Advantage of Cell-Penetrating Peptides over Receptor-Specific Antibodies in Targeting Antigen to Human Dendritic Cells for Cross-Presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

Mucosal vaccines: the promise and the challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Mucosal AIDS vaccines: current status and future directions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Strategies for designing and optimizing new generation vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Tentative T cells: memory cells are quick to respond, but slow to divide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

TGF-beta in intestinal lymphoid organs contributes to the death of armed effector CD8 T cells and is associated with the absence of virus containment in rhesus macaques infected with the simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Memory CD8 T-cell compartment grows in size with immunological experience

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Preferential localization of effector memory cells in nonlymphoid tissue

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Dynamic programming of CD8+ T cell trafficking after live viral immunization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Activation phenotype, rather than central- or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

The immunogenicity of single and combination DNA vaccines against tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Incomplete effector/memory differentiation of antigen-primed CD8+ T cells in gene gun DNA-vaccinated mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Comment on "trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination"

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Mucosal dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Generation of gut-homing T cells and their localization to the small intestinal mucosa

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Intestinal Bacteria Trigger T Cell-Independent Immunoglobulin A2 Class Switching by Inducing Epithelial-Cell Secretion of the Cytokine APRIL

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Engineered expression of the TLR5 ligand flagellin enhances paramyxovirus activation of human dendritic cell function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Retinoic acid imprints gut-homing specificity on T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

The induction of systemic and mucosal immune responses to antigen-adjuvant compositions administered into the skin: alterations in the migratory properties of dendritic cells appears to be important for stimulating mucosal immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Immunostimulant patch containing heat-labile enterotoxin from Escherichia coli enhances immune responses to injected influenza virus vaccine through activation of skin dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Isolated lymphoid follicles can function as sites for induction of mucosal immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 ΔV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Sublingual vaccination with influenza virus protects mice against lethal viral infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIV(mac251).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Human monocytes/macrophages are a target of Neisseria meningitidis Adhesin A (NadA).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Design and selection of vaccine adjuvants: animal models and human trials

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Modulating the adjuvanticity of alum by co-administration of muramyl di-peptide (MDP) or Quil-A.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Molecular and cellular signatures of human vaccine adjuvants.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Vaccine adjuvants alter TCR-based selection thresholds.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

https://api.crossref.org/works/10.1002%2FEJI.200939269

1 reference

7 January 2021

Host factors impacting the innate response in humans to the candidate adjuvants RC529 and monophosphoryl lipid A.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Virus-like particles: passport to immune recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Lipid A and liposomes containing lipid A as antigens and adjuvants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Virus-sized vaccine delivery systems

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Comparison of intranasal with targeted lymph node immunization using PR8-Flu ISCOM adjuvanted HIV antigens in macaques

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Effect of synthetic lipopeptides formulated in liposomes on the maturation of human dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Maturation of dendritic cells with lipopeptides that represent vaccine candidates for hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: characterization of CD8+-T-cell epitopes recognized.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Improved intranasal immunization with live-attenuated measles virus after co-inoculation of the lipopeptide MALP-2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Mast cell activators: a new class of highly effective vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Development of small, homogeneous pDNA particles condensed with mono-cationic detergents and encapsulated in a multifunctional envelope-type nano device

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Combination dual responsive polypeptide vectors for enhanced gene delivery

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

The mechanism of cholera toxin adjuvanticity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Effective nasal influenza vaccine delivery using chitosan

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Induction of protective serum meningococcal bactericidal and diphtheria-neutralizing antibodies and mucosal immunoglobulin A in volunteers by nasal insufflations of the Neisseria meningitidis serogroup C polysaccharide-CRM197 conjugate vaccine mixed

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Mucoadhesive DL-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Mucoadhesive nanoparticulate systems for peptide drug delivery

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Enhancement of CD8+ T cell immunity in the lung by CpG oligodeoxynucleotides increases protective efficacy of a modified vaccinia Ankara vaccine against lethal poxvirus infection even in a CD4-deficient host

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939269

7 January 2021

Identifiers

DOI

10.1002/EJI.200939269

1 reference

release_bcyelhtykrcbfcpyfii4vjmxli

21 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bcyelhtykrcbfcpyfii4vjmxli

24 November 2022

mapped directly with Wikidata item

1 reference